Camp4 Therapeutics Corp: Coastlands Capital LP amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Coastlands Capital LP amended its Schedule 13G filing on Camp4 Therapeutics Corp, disclosing a revised passive stake in the clinical-stage biotech. The filing, carrying SEC accession number 0001104659-26-127409, updates the investor's previously reported ownership position. Schedule 13G amendments are typically triggered when a passive holder's stake crosses or moves materially past the 5% threshold, though the filing summary did not specify the exact percentage. The change matters because it signals a shift in institutional ownership for the small-cap company, which can affect liquidity and shareholder composition. Investors will watch for the full filing details to confirm the size and direction of Coastlands' position and whether further amendments follow.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Coastlands Capital LP, Camp4 Therapeutics Corp